Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 33:876-882
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le Tourneau, T.
Right arrow Articles by Bertrand, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Tourneau, T.
Right arrow Articles by Bertrand, M. E.

EXPERIMENTAL STUDIES

Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: effects on neointimal hyperplasia and vascular remodeling

Thierry Le Tourneau, MDa, Eric Van Belle, MDa, Delphine Corseaux, PhDa, Benoît Vallet, MDa, Gilles Lebuffe, MDa, Bernard Dupuis, MDa, Jean-Marc Lablanche, MD, FACCa, Eugène McFadden, MRCPI, FACCa, Christophe Bauters, MD, FACCa and Michel E. Bertrand, MD, FACCa

a University and CHRU of Lille, Lille, France

Manuscript received January 12, 1998; revised manuscript received September 21, 1998, accepted November 2, 1998.

Reprint requests and correspondence: Dr. Christophe Bauters, Service de Cardiologie B, Hôpital Cardiologique, Boulevard du Professeur J Leclercq, 59037 Lille Cedex, France

OBJECTIVES

The purpose of this study was to assess the effects of L-arginine and NG-nitro-L-arginine methyl ester (L-NAME) on neointimal hyperplasia and vascular remodeling after balloon angioplasty in the hypercholesterolemic rabbit.

BACKGROUND

Restenosis after balloon angioplasty is a consequence of both neointimal hyperplasia and vessel remodeling. Nitric oxide inhibits neointimal hyperplasia, but its effect on vessel remodeling is unknown.

METHODS

Six weeks after induction of bilateral iliac atherosclerosis, 48 rabbits underwent successful angioplasty in 75 vessels. Eight rabbits (acute group) were sacrificed immediately after angioplasty. The remaining animals received either placebo (chronic control group), or a diet supplemented with either L-arginine (1.5 g/kg/day), or L-NAME (15 mg/kg/day) for 4 weeks after angioplasty.

RESULTS

The intimal area was significantly greater in the chronic control group compared to the acute group (2.60 ± 1.03 mm2 vs. 1.35 ± 0.62 mm2). This increase in intimal area was lower in the L-arginine group (1.79 ± 0.61 mm2), and greater in the L-NAME group (3.23 ± 0.92 mm2). The area circumscribed by the internal elastic lamina (IEL) increased significantly in the control group compared to the acute group (from 2.52 ± 0.66 to 3.33 ± 0.85 mm2); a more marked increase occurred in the L-NAME group (3.90 ± 0.85 mm2). By contrast, IEL area was unchanged in the L-arginine group (2.41 ± 0.62 mm2). As a result, there was no significant difference in lumen area after 4 weeks in the chronic groups (control: 0.74 ± 0.38 mm2; L-arginine: 0.50 ± 0.43 mm2; L-NAME: 0.48 ± 0.42 mm2).

CONCLUSIONS

Our results demonstrate that L-arginine inhibits whereas L-NAME stimulates neointimal hyperplasia after experimental balloon angioplasty in the hypercholesterolemic rabbit. However, the lack of vessel enlargement in the L-arginine group resulted in a similar final lumen size in the L-NAME and L-arginine groups.

Abbreviations and Acronyms
  EEL = external elastic lamina
  IEL = internal elastic lamina
  ISDN = isosorbide dinitrate
  L-NAME = NG-nitro-L-arginine methyl ester
  NO = nitric oxide




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
C.-C. Wu, S.-C. Wen, C.-W. Yang, S.-Y. Pu, K.-C. Tsai, and J.-W. Chen
Plasma ADMA Predicts Restenosis of Arteriovenous Fistula
J. Am. Soc. Nephrol., January 1, 2009; 20(1): 213 - 222.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Cardounel, H. Cui, A. Samouilov, W. Johnson, P. Kearns, A.-L. Tsai, V. Berka, and J. L. Zweier
Evidence for the Pathophysiological Role of Endogenous Methylarginines in Regulation of Endothelial NO Production and Vascular Function
J. Biol. Chem., January 12, 2007; 282(2): 879 - 887.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T.-M. Lu, Y.-A. Ding, S.-J. Lin, W.-S. Lee, and H.-C. Tai
Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention
Eur. Heart J., November 1, 2003; 24(21): 1912 - 1919.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. CONDORELLI, J. K. AYCOCK, G. FRATI, and C. NAPOLI
Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice
FASEB J, October 1, 2001; 15(12): 2162 - 2170.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Napoli, G. Cirino, P. Del Soldato, R. Sorrentino, V. Sica, M. Condorelli, A. Pinto, and L. J. Ignarro
Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice
PNAS, February 27, 2001; 98(5): 2860 - 2864.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Kawashima, T. Yamashita, M. Ozaki, Y. Ohashi, H. Azumi, N. Inoue, K.-i. Hirata, Y. Hayashi, H. Itoh, and M. Yokoyama
Endothelial NO Synthase Overexpression Inhibits Lesion Formation in Mouse Model of Vascular Remodeling
Arterioscler. Thromb. Vasc. Biol., February 1, 2001; 21(2): 201 - 207.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. P. Cooke
Does ADMA Cause Endothelial Dysfunction?
Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20(9): 2032 - 2037.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Pasterkamp, D. P.V de Kleijn, and C. Borst
Arterial remodeling in atherosclerosis, restenosis and after alteration of blood flow: potential mechanisms and clinical implications
Cardiovasc Res, March 1, 2000; 45(4): 843 - 852.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Sinnaeve, O. Varenne, D. Collen, and S. Janssens
Gene therapy in the cardiovascular system: an update
Cardiovasc Res, December 1, 1999; 44(3): 498 - 506.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
I. Six, E. Van Belle, R. Bordet, D. Corseaux, J. Callebert, B. Dupuis, C. Bauters, and M. E. Bertrand
L-Arginine and L-NAME have no effects on the reendothelialization process after arterial balloon injury
Cardiovasc Res, August 15, 1999; 43(3): 731 - 738.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Napoli, G. Aldini, J. L. Wallace, F. de Nigris, R. Maffei, P. Abete, D. Bonaduce, G. Condorelli, F. Rengo, V. Sica, et al.
Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis
PNAS, February 5, 2002; 99(3): 1689 - 1694.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. J. Sierevogel, E. Velema, P. P. de Jaegere, D. P. de Kleijn, C. Borst, and G. Pasterkamp
Minimal Duration of Oral Matrix Metalloproteinase Inhibition to Prevent Constrictive Arterial Remodeling after Balloon Dilation in the Pig
Radiology, February 1, 2002; 222(2): 468 - 473.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement